Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Non-Standardized Food Allergenic Extract [EPC]
Stillingia Sylvatica Root is a botanical agent primarily utilized as a non-standardized allergenic extract and nitrogen binding agent, historically recognized for its anti-inflammatory and alterative properties in traditional medicine.
Name
Stillingia Sylvatica Root
Raw Name
STILLINGIA SYLVATICA ROOT
Category
Non-Standardized Food Allergenic Extract [EPC]
Drug Count
22
Variant Count
23
Last Verified
February 17, 2026
About Stillingia Sylvatica Root
Stillingia Sylvatica Root is a botanical agent primarily utilized as a non-standardized allergenic extract and nitrogen binding agent, historically recognized for its anti-inflammatory and alterative properties in traditional medicine.
Detailed information about Stillingia Sylvatica Root
This page is for informational purposes only and does not replace medical advice. Consult a qualified healthcare professional before using any medication containing Stillingia Sylvatica Root.
Stillingia Sylvatica Root, commonly referred to as Queen's Delight, is a perennial herb native to the southeastern United States. In contemporary clinical pharmacology, it is classified primarily as a Non-Standardized Plant Allergenic Extract [EPC] and a Nitrogen Binding Agent [EPC]. Historically, it was a cornerstone of the Eclectic medical movement in the 19th century, where it was utilized as an 'alterative'—a substance believed to restore healthy metabolic function and 'purify' the blood. Stillingia Sylvatica Root belongs to the Euphorbiaceae family, a group of plants known for containing complex diterpene esters and acrid resins.
From a regulatory perspective, Stillingia Sylvatica Root is often encountered in the context of allergenic extracts used for diagnostic testing or immunotherapy. The FDA classifies these as biological products. While its use in mainstream internal medicine has waned in favor of synthetic alternatives, its pharmacological profile remains a subject of interest due to its diverse EPC classifications, which include roles as a Pediculicide, Adrenocorticotropic Hormone [EPC] analog, and even as a component in certain Nitrogen Binding protocols. It is important to distinguish between the raw botanical root used in traditional preparations and the highly processed, non-standardized extracts used in clinical allergy settings.
According to the pharmacological data, Stillingia Sylvatica Root exhibits a dual mechanism of action involving Ammonium Ion Binding Activity [MoA] and Corticosteroid Hormone Receptor Agonism [MoA]. At the molecular level, the active constituents—primarily diterpene esters (such as stillingia factors) and the alkaloid stillingine—interact with cellular pathways to modulate inflammatory responses.
As a Corticosteroid Hormone Receptor Agonist, compounds within the root are thought to bind to glucocorticoid receptors, mimicking the effects of endogenous cortisol. This binding initiates a cascade that inhibits the expression of pro-inflammatory cytokines and enzymes, such as cyclooxygenase-2 (COX-2). This explains its historical use in treating chronic skin conditions and systemic inflammation. Furthermore, its role as a Nitrogen Binding Agent suggests an ability to facilitate the clearance of nitrogenous waste products. The Ammonium Ion Binding Activity is particularly significant in theoretical models of metabolic detoxification, where the extract may help sequester free ammonia, thereby reducing the burden on the urea cycle and hepatic processing.
The pharmacokinetic data for Stillingia Sylvatica Root is largely derived from studies of its primary chemical constituents, as the whole-root extract contains a complex matrix of molecules.
Stillingia Sylvatica Root is utilized in several distinct clinical contexts:
Stillingia Sylvatica Root is available in several preparations, though availability varies by region and clinical application:
> Important: Only your healthcare provider can determine if Stillingia Sylvatica Root is right for your specific condition.
Dosage for Stillingia Sylvatica Root must be highly individualized, as the concentration of active resins can vary significantly between harvests.
Stillingia Sylvatica Root is generally NOT recommended for pediatric use. The acrid constituents can cause severe gastrointestinal distress in children, and there is insufficient safety data regarding its corticosteroid-like effects on developing endocrine systems. If a healthcare provider deems it necessary, doses are typically calculated using Clark's Rule or Body Surface Area (BSA), but this is rare and should only occur under strict specialist supervision.
Because the metabolites of Stillingia Sylvatica Root are primarily excreted through the kidneys, patients with a Glomerular Filtration Rate (GFR) below 60 mL/min/1.73m² should use this agent with extreme caution. A 25-50% dose reduction may be necessary to prevent the accumulation of potentially toxic alkaloids.
As the liver is responsible for the metabolic transformation of diterpene esters, patients with Child-Pugh Class B or C hepatic impairment should avoid Stillingia Sylvatica Root. Impaired metabolism can lead to increased systemic exposure and an elevated risk of hepatotoxicity.
Geriatric patients often have reduced physiological reserve and may be more sensitive to the purgative effects of the root. Dosing should start at the lowest end of the spectrum (e.g., 0.25 mL of tincture) to assess tolerance.
If you miss a dose, take it as soon as you remember. However, if it is nearly time for your next scheduled dose, skip the missed dose and resume your regular schedule. Do not double the dose to catch up, as this significantly increases the risk of emesis (vomiting) and gastrointestinal burning.
Signs of overdose include severe nausea, persistent vomiting, watery diarrhea (sometimes bloody), burning sensations in the mouth and esophagus, and tachycardia (rapid heart rate). In severe cases, it may lead to dehydration and electrolyte imbalances.
Emergency Measures: If an overdose is suspected, contact a poison control center immediately. Treatment is primarily supportive, focusing on fluid replacement and gastric protection. Do not induce vomiting if the patient has already experienced significant emesis.
> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose without medical guidance.
Due to its high resin content, Stillingia Sylvatica Root frequently causes localized irritation. Common effects include:
> Warning: Stop taking Stillingia Sylvatica Root and call your doctor immediately if you experience any of these.
Prolonged use of Stillingia Sylvatica Root (longer than 4-6 weeks) may lead to 'Stillingism,' a historical term describing a state of chronic irritation of the mucous membranes, characterized by a persistent cough, watery eyes, and digestive weakness. Furthermore, because of its Corticosteroid Hormone Receptor Agonist [MoA], long-term use could theoretically lead to secondary adrenal suppression or features of Cushingoid syndrome, though clinical data on this specific botanical is sparse compared to synthetic steroids.
There are currently no FDA Black Box Warnings specifically for Stillingia Sylvatica Root. However, as a non-standardized allergenic extract, it carries a general warning for all allergenic products regarding the risk of severe systemic allergic reactions, including anaphylaxis, which can be fatal. These products should only be administered in settings equipped to handle such emergencies.
Report any unusual symptoms to your healthcare provider.
Stillingia Sylvatica Root is a potent botanical agent with a narrow therapeutic index. It should never be used in its fresh state, as the fresh root contains highly volatile and acrid compounds that can cause severe mucosal blistering. Patients must be aware that 'natural' does not equate to 'safe,' and the pharmacological activity of this root—particularly its nitrogen-binding and corticosteroid-mimicking effects—can significantly alter systemic physiology.
No FDA black box warnings for Stillingia Sylvatica Root. However, clinicians are advised that allergenic extracts carry inherent risks of life-threatening allergic reactions.
For patients using Stillingia Sylvatica Root for more than 14 days, the following monitoring is recommended:
While Stillingia Sylvatica Root does not typically cause sedation, the potential for dizziness and sudden gastrointestinal distress may impair a patient's ability to safely operate heavy machinery. Patients should assess their individual response before engaging in these activities.
Alcohol should be avoided while taking Stillingia Sylvatica Root. Alcohol can exacerbate the gastric irritant effects of the root's resins and may increase the risk of liver strain when combined with the plant's alkaloids.
Because of its potential corticosteroid-like activity, Stillingia Sylvatica Root should not be discontinued abruptly after long-term use. A gradual tapering of the dose over 1-2 weeks is recommended to allow the HPA axis to normalize and to prevent a 'rebound' of inflammatory symptoms.
> Important: Discuss all your medical conditions with your healthcare provider before starting Stillingia Sylvatica Root.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking.
Stillingia Sylvatica Root must NEVER be used in the following circumstances:
Conditions requiring careful risk-benefit analysis include:
Patients allergic to the following may be at higher risk of reacting to Stillingia Sylvatica Root:
> Important: Your healthcare provider will evaluate your complete medical history before prescribing Stillingia Sylvatica Root.
Stillingia Sylvatica Root is strictly contraindicated during pregnancy. It is classified by many herbal monographs as a Category X-equivalent in terms of botanical safety. The presence of oxytocic [EPC] properties means it can stimulate uterine contractions. Furthermore, the diterpene esters may be teratogenic (cause birth defects), although human data is lacking. Its use in fertility treatments is not supported by clinical evidence and is generally discouraged due to potential endocrine disruption.
It is unknown if the active alkaloids and resins of Stillingia pass into breast milk. However, many low-molecular-weight compounds in the Euphorbiaceae family do cross into milk and could cause colic, diarrhea, or skin rashes in the nursing infant. Due to the risk of toxicity, breastfeeding should be discontinued if the mother must use Stillingia Sylvatica Root.
Stillingia is not approved for use in children. The risk of severe gastrointestinal irritation and the potential for the root to interfere with natural growth hormones (via its corticosteroid-like activity) make it unsafe for pediatric populations. Cases of accidental ingestion should be treated as emergencies.
Elderly patients are at a higher risk for adverse effects, particularly dehydration from the root's purgative action and potential falls due to dizziness. Because renal function naturally declines with age, the risk of alkaloid accumulation is higher. Geriatric patients are also more likely to be on multiple medications (polypharmacy), increasing the risk of drug-drug interactions with anticoagulants or diuretics.
In patients with renal impairment, the clearance of Stillingia metabolites is significantly reduced. This can lead to a prolonged half-life and increased systemic toxicity. Dosing should be avoided in patients with end-stage renal disease (ESRD) unless the benefits clearly outweigh the risks, and even then, only with frequent monitoring of drug levels if possible.
Patients with hepatic impairment (Child-Pugh Class B or C) should avoid Stillingia Sylvatica Root. The liver's inability to conjugate and detoxify the diterpene esters can lead to direct hepatocyte damage and systemic poisoning. There are no established dosing guidelines for this population, making avoidance the safest course of action.
> Important: Special populations require individualized medical assessment.
Stillingia Sylvatica Root acts through a complex interplay of botanical constituents. The primary mechanism involves Corticosteroid Hormone Receptor Agonism. Specific diterpene esters within the root extract have a high affinity for glucocorticoid receptors. Upon binding, these compounds promote the translocation of the receptor into the nucleus, where it modulates gene transcription to reduce the production of inflammatory mediators.
Additionally, the root functions as a Nitrogen Binding Agent. It appears to enhance the sequestration of ammonium ions ($NH_4^+$), possibly through direct chemical binding or by upregulating pathways involved in nitrogenous waste excretion. This Ammonium Ion Binding Activity [MoA] is thought to reduce systemic ammonia levels, which has implications for metabolic and hepatic health.
The dose-response relationship of Stillingia is non-linear. Small doses may provide anti-inflammatory effects, while larger doses rapidly transition into emetic and cathartic effects. The time to onset for gastrointestinal irritation is 15-30 minutes, while the systemic anti-inflammatory effects may take 24-48 hours of consistent dosing to manifest. Tolerance to the acrid effects does not typically develop; rather, the tissues often become more sensitized over time.
| Parameter | Value |
|---|---|
| Bioavailability | 30-45% (Estimated) |
| Protein Binding | 60-70% (Estimated) |
| Half-life | 4-8 hours |
| Tmax | 1.5-2 hours |
| Metabolism | Hepatic (CYP3A4 suspected) |
| Excretion | Renal 75%, Fecal 25% |
Stillingia Sylvatica Root contains a variety of active compounds, including the alkaloid stillingine, the glycoside stillingin, and several diterpene esters known as stillingia factors. The root also contains about 3% acrid resin and 2% volatile oil. The molecular formula for the primary alkaloid stillingine is complex, contributing to its significant biological activity. It is soluble in alcohol and partially soluble in boiling water.
Stillingia Sylvatica Root is classified as a Non-Standardized Plant Allergenic Extract [EPC] and a Nitrogen Binding Agent [EPC]. It shares therapeutic space with other botanical alteratives like Sarsaparilla and Arctium lappa, as well as pharmaceutical nitrogen binders like sodium benzoate.
Common questions about Stillingia Sylvatica Root
Stillingia Sylvatica Root is primarily used as a non-standardized allergenic extract for diagnostic allergy testing. Historically, it was used in traditional medicine as an 'alterative' to treat chronic skin conditions like psoriasis and eczema, and to support lymphatic drainage. Modern pharmacological data also identifies it as a nitrogen binding agent and a corticosteroid receptor agonist. Its use today is mostly limited to specialized allergy clinics and integrative medicine practices. Always consult a healthcare provider before using this root for any medical condition.
The most common side effects are gastrointestinal in nature, including nausea, vomiting, and a distinct burning sensation in the mouth, throat, and stomach. This is due to the acrid resins found in the root. Other frequent side effects include increased salivation and sweating. If taken in high doses, it acts as a potent purgative, causing watery diarrhea. These symptoms usually occur shortly after ingestion and can be quite distressing.
No, you should avoid drinking alcohol while taking Stillingia Sylvatica Root. Alcohol can increase the irritant effects of the root's resins on the stomach lining, raising the risk of gastritis or ulcers. Furthermore, both alcohol and Stillingia are processed by the liver, and combining them may place undue stress on hepatic function. Alcohol may also worsen the dizziness that some people experience when taking this botanical. Always prioritize liver health when using potent plant extracts.
Stillingia Sylvatica Root is considered unsafe during pregnancy and should be strictly avoided. It has historical use as an emmenagogue, meaning it can stimulate blood flow to the pelvic area and uterus. Additionally, it has oxytocic properties that may trigger uterine contractions, potentially leading to miscarriage or preterm labor. There is also a lack of safety data regarding the effects of its active alkaloids on a developing fetus. Pregnant women should consult their obstetrician before taking any herbal supplement.
The onset of action for Stillingia Sylvatica Root depends on the desired effect. The irritant effects on the digestive system and the oropharynx occur almost immediately, typically within 15 to 30 minutes. However, the systemic anti-inflammatory and 'blood purifying' effects associated with its corticosteroid-like activity may take several days or even weeks of consistent use to become noticeable. For allergenic skin testing, a reaction usually appears within 15 to 20 minutes of application. Results vary significantly between individuals.
If you have been taking Stillingia Sylvatica Root for an extended period, you should not stop taking it suddenly. Because it acts as a corticosteroid hormone receptor agonist, your body's natural hormone production may have adjusted to its presence. Abrupt discontinuation could theoretically lead to a rebound of inflammatory symptoms or a mild form of adrenal insufficiency. It is best to work with your healthcare provider to gradually taper your dose over one to two weeks. This ensures your system returns to its baseline safely.
If you miss a dose of Stillingia Sylvatica Root, take it as soon as you remember. If it is almost time for your next dose, skip the missed one and continue with your regular schedule. Never take two doses at once to make up for a missed one, as this significantly increases the risk of severe nausea and vomiting. Consistency is important for therapeutic effects, but safety is paramount. If you frequently miss doses, consider using a pill reminder or alarm.
There is no direct evidence that Stillingia Sylvatica Root causes weight gain. However, because it has corticosteroid-like activity, long-term use at high doses could theoretically cause side effects similar to prescription steroids, such as fluid retention or changes in fat distribution. These effects are not typical with standard short-term use. If you notice unusual swelling or rapid weight gain while taking this root, contact your doctor. Most patients do not experience weight changes with this agent.
Stillingia Sylvatica Root has several significant drug interactions and should be used cautiously with other medications. It should not be combined with prescription corticosteroids, as this can lead to dangerous additive effects. It may also interact with diuretics, blood thinners, and medications for diabetes. Because it is a nitrogen binding agent, it can affect how other drugs are processed and excreted. Always provide your healthcare provider with a full list of your current medications before starting Stillingia.
Stillingia Sylvatica Root is a botanical substance and is not sold as a 'generic' in the same way as synthetic drugs like lisinopril. Instead, it is available as various non-branded herbal extracts, tinctures, and bulk dried roots from different manufacturers. In the context of allergenic extracts, these are biological products that are often non-standardized. While many brands may sell 'Queen's Delight,' the quality and concentration of active ingredients can vary widely between products. Look for reputable suppliers who provide certificates of analysis.